GFAP and infection: As shown in Figure 6, we observed a significant increase in expression of GFAP and Iba1 in the infected group 10 weeks after the infection; in comparison, the artesunate-treated group, with treatment started two weeks after the infection, showed a significant reduction of GFAP and Iba1 expression in spinal cord tissue.